Protein Summary
Involved in the regulation of cell cycle progression, this activity is related to the inhibition of apoptosis following the removal of essential growth factors (PubMed:12145692). Exhibits H3K4me3-binding activity (PubMed:29061846).
- ENST00000275988
- ENSP00000275988
- ENSG00000186787
- ENST00000333933
- ENSP00000335008
- SPIN2
- SPIN-2
- TDRD26
- SPIN-2B
- dJ323P24.2
- SPIN2_duplicate
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
virus perturbation | 0.76 | ||
histone modification site profile | 0.73 | ||
cell type or tissue | 0.62 | ||
tissue sample | 0.56 | ||
tissue | 0.49 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 16.09 (req: < 5)
Gene RIFs: 1 (req: <= 3)
Antibodies: 69 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 16.09 (req: >= 5)
Gene RIFs: 1 (req: > 3)
Antibodies: 69 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 5
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 2
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0